Texas MedicaidLow ImpactCoverage
Age Restriction Update for Beremagene Geperpavec-Svdt (Vyjuvek) Procedure Code J3401
Published January 24, 2026Effective March 1, 2026
AI Summary
Effective March 1, 2026, the FDA has approved age expansion for beremagene geperpavec-svdt (Vyjuvek) procedure code J3401 to include adult and pediatric clients of all ages, removing previous age restrictions. This change applies to Texas Medicaid and managed care organizations must provide this medically necessary service to enrolled members.
Action Required
Before March 1, 2026: Billing team must update system settings to remove age restrictions for HCPCS code J3401 (beremagene geperpavec-svdt/Vyjuvek). Contact specific Texas Medicaid MCOs to verify any administrative requirements like prior authorization or referrals, as these may vary by plan. Update encounter forms to reflect expanded age eligibility.
Affected Billing Codes
J3401
Plan Types
Medicaid
States
TX
Specialties
dermatology, pediatrics